P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY

• Wu Mei,
• Zhu Lin,
• LI Shan,
• Tu Erde Jia Erbao,
• Wang Shanshan,
• Liang Xiao,
• Hu Xin,
• Guo LI,
• A Dili Abulikemujiang,
• Maimaitirexiati Xianmusiya,
• Ren Ruirui,
• Wen Shujuan

Affiliations

Wu Mei

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Zhu Lin

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

LI Shan

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Tu Erde Jia Erbao

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Wang Shanshan

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Liang Xiao

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Hu Xin

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Guo LI

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

A Dili Abulikemujiang

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Maimaitirexiati Xianmusiya

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Ren Ruirui

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China

Wen Shujuan

1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China